Items tagged with Drug-resistant TB
Obama Administration takes actions to combat antibiotic-resistant bacteria (post with simple image)
President Obama signed an Executive Order directing key Federal departments and agencies to take action to combat the rise of antibiotic-resistant bacteria.
A deadly disease that demands huge investment (post with simple image)
Tuberculosis is by far the biggest single cause of death in South Africa, and it is exacerbated by the HIV epidemic.
South Africa: Bedaquiline approved to treat multidrug-resistant tuberculosis (post with simple image)
The Medicines Control Council has approved Janssen Pharmaceutica’s bedaquiline, the first drug specifically designed for treating multidrug-resistant tuberculosis (MDR-TB) to reach the market.
PA-824 has a new generic name: pretomanid (post with simple image)
Pretomanid is a component of two new TB drug regimens being tested by TB Alliance for their ability to transform TB therapy, as well as future planned trials.
UNITAID’s EXPAND-TB and TBXpert MTB-RIF projects detect over a quarter of all MDR-TB cases (post with simple image)
Geneva, 22nd October 2014 – UNITAID welcomes new data in the World Health Organization’s new global report on tuberculosis (TB) which shows a 30% increase in case detection of multi-drug resistant TB (MDR-TB) in 2013, much of which is attributed to the roll out of the UNITAID-funded EXPAND-TB and TBXpert projects.
Report launch: Falling short (post with simple image)
A civil society perspective of the response to multi & extensively drug resistant tuberculosis (M/XDR-TB) in the European region
MSF response to release of new WHO global tuberculosis report 2014 (post with simple image)
The World Health Organization (WHO) has released their Global Tuberculosis Report 2014. While TB incidence and mortality rates from TB continue to fall, MSF notes alarming trends in the drug-resistant TB (DR-TB) epidemic and urges action to reverse course.
Success short treatment against drug-resistant tuberculosis confirmed (post with simple image)
The result of 10 years of collaboration between the Damien Foundation Belgium and the Institute of Tropical Medicine in Antwerp (ITM) could revolutionize global tuberculosis control.
Bedaquiline as part of tailored therapy for MDR- and XDR-TB achieves impressive culture conversion rates (post with simple image)
Bedaquiline combined with other active drugs has the potential to achieve high culture conversion rates in advanced MDR- and XDR-TB cases. However, it is crucial to follow carefully all patients for severe adverse events, even after bedaquiline discontinuation.
WHO interim guidance on the use of delamanid in the treatment of MDR-TB (post with simple image)
The guidance lists five conditions that must be in place if delamanid is used to treat adults with MDR-TB.
Page 59 of 71 · Total posts: 0←First 58 59 60 Last→